Mackenzie Financial’s NuVasive, Inc. NUVA Stock Holding History

Mackenzie Financial’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,785	Closed	-$404K	–	1635
2022 Q4	$404K	Buy	+9,785	New	+$396K	﹤0.01%	999
2020 Q3	–	Sell	-3,800	Closed	-$212K	–	1070
2020 Q2	$212K	Sell	3,800 -680	-15%	-$39.3K	﹤0.01%	936
2020 Q1	$227K	Buy	+4,480	New	+$300K	﹤0.01%	963

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Mackenzie Financial's NUVA Position: Q1 2023 in Review

Mackenzie Financial sold out of NuVasive, Inc. (NUVA) in Q1 2023, closing a stake of 9,785 shares — an estimated $404K sold.

Mackenzie Financial first reported a position in NUVA in Q1 2020 and held it in 3 quarters. The position peaked at $404K in Q4 2022. 241 funds tracked by Wall St. Rank hold NUVA as of Q1 2023.

Mackenzie Financial reported no remaining NuVasive, Inc. position as of Q1 2023 after selling out during the quarter.
Mackenzie Financial sold 9,785 NuVasive, Inc. shares in Q1 2023, an estimated $404K.
Mackenzie Financial first reported a position in NuVasive, Inc. in Q1 2020 and held it in 3 quarters.
Mackenzie Financial's NuVasive, Inc. position peaked at $404K in Q4 2022.
241 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2023.

Based on Mackenzie Financial's 13F filing for Q1 2023, filed 24 Apr 2023.